Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer

Cancer Research

Volumn 65, Issue 5, 2005, Pages 1664-1669

  Pan, Hongjie ^a   Califano, Joseph ^b   Ponte, Jose F ^a   Russo, Andrea L ^a   Cheng, Kuang Hung ^a   Thiagalingam, Arunthathi ^a,c   Nemani, Pratima ^a   Sidransky, David ^b   Thiagalingam, Sam ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; BRONCHUS MUCOSA; CANCER GROWTH; CANCER STAGING; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 3P; CHROMOSOME 5Q; CHROMOSOME 8P; CHROMOSOME 9P; CIGARETTE SMOKING; CONTROLLED STUDY; DNA FINGERPRINTING; EPITHELIUM CELL; FEMALE; FISHER EXACT TEST; FREQUENCY ANALYSIS; GENE ACTIVATION; GENE INACTIVATION; GENE LOCATION; GENE TARGETING; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; AGED; ALLELES; BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN; DERMATOGLYPHICS; DISEASE PROGRESSION; DNA, NEOPLASM; EPITHELIAL CELLS; FEMALE; GENETIC HETEROGENEITY; GENOTYPE; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; SMOKING;

EID: 16444374716     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3297     Document Type: Article

References (42)

1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 1996;46:5-27.
3. Minna JD. Neoplasms of the lung. In: Braunwald E, IsselBacher K, Petersdorf R, Wilson J, Martin J, Fauci A, editors. Harrison's principles of internal medicine. New York: McGraw-Hill; 1994. p. 1221-9.
4. Travis WD, Linder J, MacKay B. Classification, histology, cytology, and electron microscopy. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, Minna JD, editors. Lung cancer principles and practice. 2nd ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2000. p. 453-95.
5. Nelkin BD, Mabry M, Baylin SB. Lung cancer. In: Scriver CR, Beaudet AL, Valle D, Sly WS, Kinzler KW, Vogelstein B, editors. The metabolic and molecular bases of inherited disease. Vol. 1. New York: McGraw-Hill; 2001. p. 1147-55.
6. Gazdar AF, Bader S, Hung J, et al. Molecular genetic changes found in human lung cancer and its precursor lesions. Cold Spring Harb Symp Quant Biol 1994;59:565-72.
7. Kohno T, Takahashi M, Manda R, Yokota J. Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers. Genes Chromosomes Cancer 1998;22:152-6.
8. Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol 2002;64:681-708.
9. Thiagalingam S, Foy RL, Cheng K-H, et al. Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence. Curr Opin Oncol 2002;14:65-72. Corrected and republished from: Curr Opin Oncol 2002;14:374.
10. Virmani AK, Fong KM, Kodagoda D, et al. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer 1998;21:308-19.
11. Girard L, Zochbauer-Muller S, Virmani AK, et al. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 2000;60:4894-906.
12. Mao L, Lee DJ, Tockman MS, et al. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci U S A 1994;91:9871-5.
13. Thiagalingam S, Laken S, Willson JKV, et al. The mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc Natl Acad Sci U S A 2001;98:2698-702.
14. Mao L, Lee JS, Kurie JM, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997;89:857-62.
15. Sanchez-Cespedes M, Ahrendt SA, Piantadosi S, et al. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res 2001;61:1309-13.
16. Ishikawa Y, Furuta R, Miyoshi T, et al. Loss of heterozygosity and the smoking index increase with decrease in differentiation of lung adenocarcinomas: etiologic implications. Cancer Lett 2002;187:47-51.
17. Westra WH, Slebos RJ, Offerhaus GJ, et al. K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung. Cancer 1993;72:432-8.
18. Thiagalingam S. Molecular detection of Smad4/ Smad2 alterations in colorectal tumors: colorectal cancer methods and protocols. In: Powell SM, editor. Methods in molecular medicine. Totowa (NJ): Humana Press, Inc.; 2001;50:149-65.
19. Vineis P, Alavanja M, Buffler P, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004;96:99-106.
20. Kinzler KW, Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 1997;386:761-3.
21. Okamoto A, Demetrick DJ, Spillare EA. et al. Mutations and altered expression of p16INK4 in human cancer. Proc Natl Acad Sci U S A 1994;91:11045-9.
22. Riley DJ, Lee EY, Lee WH. The retinoblastoma protein: more than a tumor suppressor. Annu Rev Cell Biol 1994;10:1-29.
23. Ortega S, Malumbres M, Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 2002;1602:73-87.
24. Chen JT, Chen YC, Wang YC, et al. Alterations of the p16(mk4a) gene in resected non-small cell lung tumors and exfoliated cells within sputum. Int J Cancer 2002;98:724-31.
25. Reissmann PT, Koga H, Takahashi R, et al. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. Oncogene 1993;8:1913-9.
26. Dosaka-Akita H, Hu SX, Fujino M, et al. Altered retinoblastoma protein expression in non-small cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis. Cancer 1997;79:1329-37.
27. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-30.
28. Semczuk A, Jakowicki JA. Alterations of pRb1-cyclin D1-cdk4/6-p16(INK4A) pathway in endometrial carcinogenesis. Cancer Lett 2004;203:1-12.
29. Sozzi G, Veronese ML, Negrini M, et al. The FHIT gene 3p14.2 is abnormal in lung cancer. Cell 1996;85:17-26.
30. Zochbauer-Muller S, Wistuba II, Minna JD, Gazdar AF. Fragile histidine triad (FHIT) gene abnormalities in lung cancer. Clin Lung Cancer 2000;2:141-5.
31. Huang K, Arabshahi A, Wei Y, Frey PA. The mechanism of action of the fragile histidine triad, Fhit: isolation of a covalent adenylyl enzyme and chemical rescue of H96G-Fhit. Biochemistry 2004;43:7637-42.
32. Thiagalingam S, Lengauer C, Leach FS, et al. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 1996;13:343-6.
33. Kinzler KW, Vogelstein B. Lessons from hereditary-colon cancer. Cell 1996;87:159-70.
34. Thiagalingam S, Cheng K-H, Foy RL, et al. TGF-β and its Smad connection to cancer. Curr Genomics 2002;3:449-76.
35. Robles AI, Linke SP, Harris CC. The p53 network in lung carcinogenesis. Oncogene 2002;21:6898-907.
36. Toyooka S, Tsuda T, Gazdar AF. The TP53 gene, tobacco exposure, and lung cancer. Hum Mutat 2003;21:229-39.
37. Nomoto S, Haruki N, Kondo M, et al. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res 1998;58:1380-3.
38. Ohgaki H, Kros JM, Okamoto Y, et al. APC mutations are infrequent but present in human lung cancer. Cancer Lett 2004;207:197-203.
39. Petersen I, Bujard M, Petersen S, et al. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 1997;57:2331-5.
40. Sato S, Nakamura Y, Tsuchiya E. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 1994;54:5652-5.
41. Wistuba II, Behrens C, Milchgrub S, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999;18:643-50.
42. Wistuba II, Behrens C, Virmani AK, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 2000;60:1949-60.